中文产业新闻评分53Chinese source
恒瑞与诺和诺德达成最高26亿美元BD交易，授权GLP-1药物HRS-1596海外权益
恒瑞＆诺和诺德，最高26亿美元BD交易达成
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
恒瑞＆诺和诺德，最高26亿美元BD交易达成
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.